Phase I/Ii Clinical Trial of Anti-Ox40, Radiation and Cyclophosphamide in Patients With Prostate Cancer: Immunological Analysis

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p255

Related search